COMMUNIQUÉS West-GlobeNewswire

-
Registration of merger, de-listing of Oncology Venture from Spotlight Stock Market, last day of trading and record date for the merger
24/08/2018 -
Xbrane Biopharma releases interim report for the second quarter of 2018
24/08/2018 -
Shire plc: Rule 2.9 Announcement
24/08/2018 -
Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema
24/08/2018 -
Navamedic ASA: Q2 2018 results
24/08/2018 -
PCI Biotech convenes an extraordinary general meeting to propose a fully underwritten Rights Issue of NOK 360 million
24/08/2018 -
Navamedic ASA: Q2 2018 results
24/08/2018 -
Kiadis Pharma to announce Financial Results for the six months ended June 30, 2018
24/08/2018 -
DiaMedica Issues Stock Option Grant
24/08/2018 -
Shire Announces FDA Approval of TAKHZYRO™ (lanadelumab-flyo), a First-of-its-Kind mAb Preventive Treatment for Hereditary Angioedema
24/08/2018 -
Telix Pharmaceuticals, University of Melbourne and Peter Mac to Collaborate on Colorectal Cancer
24/08/2018 -
Advanced Proteome Therapeutics Announces Closing of First Tranche of a Non-Brokered Private Placement
23/08/2018 -
Terry Bradshaw Encourages Patients to “Take the Pledge to Live Well” in New PSA about Rheumatic Disease
23/08/2018 -
Veloxis Increases Share Capital in Connection with Exercise of Warrants
23/08/2018 -
Cerner and Duke Clinical Research Institute Collaborate on Cardiac Risk App
23/08/2018 -
Intellia Therapeutics Presents Progress in Lead In Vivo Program at Cold Spring Harbor Laboratory’s Fourth Meeting on Genome Engineering: The CRISPR-Cas Revolution
23/08/2018 -
Immunomedics Announces Fourth Quarter and Fiscal Year 2018 Results and Provides Corporate Update
23/08/2018 -
ICC Responds to Media Reports
23/08/2018 -
Nova Leap Health Corp. Reports Second Quarter 2018 Financial Results and Provides Corporate Update
23/08/2018
Pages